[1]
Jommi, C., Cipriani, F., Fanelli, F., Pedone, M.P. and Canonica, W. 2020. The effects of disease cross-coverage by dupilumab on the costs sustained by the Italian National Health Service. Global and Regional Health Technology Assessment. 7, 1 (Jul. 2020), 33–39. DOI:https://doi.org/10.33393/grhta.2020.2139.